Mouse models of influenza infection with circulating strains to test seasonal vaccine efficacy

Helen T. Groves, Jacqueline U. McDonald, Pinky Langat, Ekaterina Kinnear, Paul Kellam, John McCauley, Joanna Ellis, Catherine Thompson, Ruth Elderfield, Lauren Parker, Wendy Barclay, John S. Tregoning*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

Influenza virus infection is a significant cause of morbidity and mortality worldwide. The surface antigens of influenza virus change over time blunting both naturally acquired and vaccine induced adaptive immune protection. Viral antigenic drift is a major contributing factor to both the spread and disease burden of influenza. The aim of this study was to develop better infection models using clinically relevant, influenza strains to test vaccine induced protection. CB6F1 mice were infected with a range of influenza viruses and disease, inflammation, cell influx, and viral load were characterized after infection. Infection with circulating H1N1 and representative influenza B viruses induced a dose-dependent disease response; however, a recent seasonal H3N2 virus did not cause any disease in mice, even at high titers. Viral infection led to recoverable virus, detectable both by plaque assay and RNA quantification after infection, and increased upper airway inflammation on day 7 after infection comprised largely of CD8 T cells. Having established seasonal infection models, mice were immunized with seasonal inactivated vaccine and responses were compared to matched and mismatched challenge strains. While the H1N1 subtype strain recommended for vaccine use has remained constant in the seven seasons between 2010 and 2016, the circulating strain of H1N1 influenza (2009 pandemic subtype) has drifted both genetically and antigenically since 2009. To investigate the effect of this observed drift on vaccine induced protection, mice were immunized with antigens from A/California/7/2009 (H1N1) and challenged with H1N1 subtype viruses recovered from 2009, 2010, or 2015. Vaccination with A/California/7/2009 antigens protected against infection with either the 2009 or 2010 strains, but was less effective against the 2015 strain. This observed reduction in protection suggests that mouse models of influenza virus vaccination and infection can be used as an additional tool to predict vaccine efficacy against drift strains.

Original languageEnglish
Article number126
JournalFrontiers in Immunology
Volume9
Issue numberJAN
DOIs
Publication statusPublished - 31 Jan 2018

Bibliographical note

Funding Information:
The authors thank Stephen Reece for advice on manuscript. The authors have no commercial conflicts of interest in this study. Giuseppe Del Giudice (GSK Vaccines, Sienna) provided the influenza vaccine antigens. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. [115308] Biovacsafe, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA members' in kind contribution. This work was supported by the European Community's European seventh Framework Program ADITEC (HEALTH-F4-2011-18 280873). The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. [115308] Biovacsafe, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA members' in kind contribution. This work was supported by the European Community's European Seventh Framework Program ADITEC (HEALTH-F4-2011-18 280873). The work done at the Crick Worldwide Influenza Centre, a WHO Collaborating Centre for Reference and Research on Influenza, was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001030), the Medical Research Council (FC001030), and the Wellcome Trust (FC001030).

Publisher Copyright:
© 2018 Groves, McDonald, Langat, Kinnear, Kellam, McCauley, Ellis, Thompson, Elderfield, Parker, Barclay and Tregoning.

Keywords

  • Antibodies
  • Infection
  • Influenza Vaccines
  • Mouse models
  • Vaccine drift
  • Viral

Fingerprint

Dive into the research topics of 'Mouse models of influenza infection with circulating strains to test seasonal vaccine efficacy'. Together they form a unique fingerprint.

Cite this